SCHEMBL950142

SCHEMBL950142

O=C1NC(=O)[C@@]2(N1)C(=O)N(C/C=C/c1ccc(Cl)c(C(F)(F)F)c1)c1ccccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.34
ALDH1A1 P00352 5/20 0.34
AKR1B1 P15121 3/20 0.34
GAA P10253 2/20 0.34
MAPT P10636 2/20 0.34
RCE1 Q9Y256 2/20 0.34
AKR1A1 P14550 2/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
C5AR1 P21730 1/20 0.33
ADAMTS5 Q9UNA0 2/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
ITGA4 P13612 1/20 0.32
MMP2 P08253 1/20 0.32
MMP14 P50281 1/20 0.32
GHSR Q92847 2/20 0.32
ALDH2 P05091 1/20 0.31
MEN1 O00255 1/20 0.31
ALPL P05186 1/20 0.31
ALPI P09923 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL949825 1.00 AR (0.34) ARALDH1A1AKR1B1GAAMAPT
SCHEMBL950827 1.00 AR (0.34) ARALDH1A1AKR1B1GAAMAPT
SCHEMBL949680 0.88 AKR1B1 (0.37) ALDH1A1AKR1B1GAAMAPTRCE1
SCHEMBL950207 0.88 AKR1B1 (0.37) ALDH1A1AKR1B1GAAMAPTRCE1
SCHEMBL953677 0.88 AKR1B1 (0.37) ALDH1A1AKR1B1GAAMAPTRCE1
SCHEMBL13781378 0.78 CHRM5 (0.35) PTGDR2
SCHEMBL4263796 0.74 ITGA4 (0.43) ALDH1A1AKR1B1GAAMAPTAKR1A1
SCHEMBL4168480 0.74 ALDH1A1 (0.36) ALDH1A1AKR1B1GAAMAPTRCE1
SCHEMBL4261580 0.73 AKR1B1 (0.44) ALDH1A1AKR1B1GAAMAPTRCE1
SCHEMBL953500 0.73 ALDH1A1 (0.60) ALDH1A1MAPTRCE1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7868181-B2 Compounds ASTRAZENECA AB (SE) 2011-01-11 US disclosed
US-20090137650-A1 New Compounds LEUNG CARMEN 2009-05-28 US disclosed
US-20070185179-A1 New compounds ASTRAZENECA AB (SE) 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137650-A1 New Compounds CLIC1, AQP1, AVPR2 AR 3835/4885ALDH1A1 1551/4885AKR1B1 847/4885
US-20070185179-A1 New compounds CLIC1, AQP1, AVPR2 AR 3835/4885ALDH1A1 1551/4885AKR1B1 847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.